This inventor holds 3 USPTO granted patents. Top assignee: Ajinomoto Co., Ltd.. Active years: 1987-1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987-1990
Title: Masabumi Yasunami: Innovator in Pharmaceutical Chemistry
Introduction
Masabumi Yasunami is a notable inventor based in Sendai, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on azulene derivatives. With a total of 3 patents to his name, Yasunami continues to push the boundaries of medicinal chemistry.
Latest Patents
Yasunami's latest patents focus on azulene derivatives and pharmaceutical compositions containing them. These compounds are characterized by specific structural formulas where R¹ and R² represent alkyl groups of 1 to 3 carbon atoms. Additionally, R³ is positioned at either the 5- or 6-position and can be an alkyl group of 1 to 6 carbon atoms, an aryl group of 6 to 9 carbon atoms, or an aralkyl group of 7 to 10 carbon atoms. These azulene derivatives exhibit antihyperlipidemic activity, making them valuable in treating lipid-related disorders. Many of these compounds are also considered novel in their own right.
Career Highlights
Yasunami is currently associated with Ajinomoto Co., Ltd., a leading company in the food and pharmaceutical industries. His work at Ajinomoto has allowed him to explore and develop innovative solutions in pharmaceutical applications. His research has not only contributed to the company's portfolio but has also advanced the field of medicinal chemistry.
Collaborations
Yasunami has collaborated with esteemed colleagues such as Kahei Takase and Takashi Meguro. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.
Conclusion
Masabumi Yasunami's contributions to the field of pharmaceutical chemistry through his innovative azulene derivatives highlight his role as a significant inventor. His work continues to impact the industry positively, paving the way for future advancements in medicinal applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
